International Assets Investment Management LLC Invests $3.75 Million in Henry Schein, Inc. (NASDAQ:HSIC)

International Assets Investment Management LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 49,590 shares of the company’s stock, valued at approximately $3,754,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Lazard Asset Management LLC lifted its holdings in Henry Schein by 1,303.3% in the third quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock valued at $92,614,000 after buying an additional 1,158,451 shares during the period. Boston Partners increased its stake in shares of Henry Schein by 4,975.9% in the 3rd quarter. Boston Partners now owns 1,080,598 shares of the company’s stock valued at $80,229,000 after acquiring an additional 1,059,309 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Henry Schein by 7.3% during the 3rd quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock valued at $350,392,000 after acquiring an additional 322,649 shares during the period. Artisan Partners Limited Partnership bought a new position in Henry Schein during the third quarter worth $19,864,000. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in Henry Schein in the third quarter worth $16,650,000. 96.62% of the stock is owned by institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 0.9 %

HSIC stock opened at $73.44 on Friday. The stock has a fifty day moving average of $72.95 and a 200-day moving average of $72.35. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The company has a market capitalization of $9.44 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 1.68 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.21 earnings per share. As a group, equities research analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on HSIC. SVB Leerink assumed coverage on shares of Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective on the stock. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. Evercore ISI upped their target price on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. JPMorgan Chase & Co. raised their price target on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. Finally, Jefferies Financial Group upped their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of “Hold” and an average target price of $81.73.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.